.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Medtronic
Chinese Patent Office
Accenture
Citi
Fish and Richardson
AstraZeneca
UBS
Argus Health
Queensland Health

Generated: November 22, 2017

DrugPatentWatch Database Preview

Warfarin potassium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for warfarin potassium and what is the scope of warfarin potassium patent protection?

Warfarin potassium
is the generic ingredient in one branded drug marketed by Pharm Res Assoc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for warfarin potassium.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharm Res Assoc
ATHROMBIN-K
warfarin potassium
TABLET;ORAL011771-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN-K
warfarin potassium
TABLET;ORAL011771-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN-K
warfarin potassium
TABLET;ORAL011771-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN-K
warfarin potassium
TABLET;ORAL011771-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Federal Trade Commission
Healthtrust
Medtronic
Citi
Mallinckrodt
Colorcon
McKesson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot